JIC
MRNA icon

Joel Isaacson & Co’s Moderna MRNA Stock Holding History

Joel Isaacson & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,475
Closed -$227K – 331
2023
Q1 		$227K Buy
1,475
+100
+7% +$16.5K 0.02% 293
2022
Q4 		$247K Buy
+1,375
New +$225K 0.02% 275
2021
Q4 		– Sell
-1,322
Closed -$509K – 314
2021
Q3 		$509K Buy
+1,322
New +$488K 0.04% 179

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Joel Isaacson & Co's MRNA Position: Q2 2023 in Review

Joel Isaacson & Co sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,475 shares — an estimated $227K sold.

Joel Isaacson & Co first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $509K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Joel Isaacson & Co reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Joel Isaacson & Co sold 1,475 Moderna shares in Q2 2023, an estimated $227K.
  • Joel Isaacson & Co first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Joel Isaacson & Co's Moderna position peaked at $509K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Joel Isaacson & Co's 13F filing for Q2 2023, filed 27 Jul 2023.